Nivolumab and Amiodorane-Induced Interstitial Lung Disease (ILD) in a Patient with Metastatic Melanoma

Title

Nivolumab and Amiodorane-Induced Interstitial Lung Disease (ILD) in a Patient with Metastatic Melanoma

Creator

Burgei J; Dasgupta R; Kim I; Makkar H

Publisher

American Journal of Respiratory and Critical Care Medicine

Date

2019
2019

Description

Thematic Poster Session, ATS Conference 2019. Presented as part of session A39: Drug Related Case Reports

Subject

Respiratory System; General & Internal Medicine

Identifier

https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A1489

Rights

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

URL Address

https://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2019.199.1_MeetingAbstracts.A1489

Search for Full-text

Users with a NEOMED Library login can search for full-text journal articles at the following url: https://libraryguides.neomed.edu/home

Pages

2

Volume

199

ISSN

1073-449X

Citation

Burgei J; Dasgupta R; Kim I; Makkar H, “Nivolumab and Amiodorane-Induced Interstitial Lung Disease (ILD) in a Patient with Metastatic Melanoma,” NEOMED Bibliography Database, accessed April 15, 2021, https://neomed.omeka.net/items/show/6421.

Social Bookmarking